Carbon Ion Radiation Therapy with Concurrent Gemcitabine for Patients with Locally Advanced Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 95, Issue 1, 2016, Pages 498-504

  Shinoto, Makoto ^a,b,c   Yamada, Shigeru ^a   Terashima, Kotaro ^c   Yasuda, Shigeo ^a   Shioyama, Yoshiyuki ^b   Honda, Hiroshi ^c   Kamada, Tadashi ^a   Tsujii, Hirohiko ^a   Saisho, Hiromitsu ^d   Asano, Takehide ^e   Yamaguchi, Taketo ^e   Amano, Hodaka ^e   Ishihara, Takeshi ^e   Otsuka, Masayuki ^e   Matsuda, Masamichi ^e   Kainuma, Osamu ^e   Funakoshi, Akihiro ^e   Furuse, Junji ^e   Nakagori, Toshio ^e   Okusaka, Takuji ^e   Ishii, Hiroshi ^e   Nagakawa, Tatsuya ^e   Takahashi, Shinichiro ^e   Hishinuma, Shoichi ^e   Nakamura, Masafumi ^e   Saito, Hirofumi ^e   Ohara, Kiyoshi ^e   Ohkawa, Shinichi ^e   Hiraoka, Masahiro ^e   more..

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Saga HIMAT Foundation   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d International University of Health and Welfare and International University of Health and Welfare Ichikawa Hospital   (Japan)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; HEAVY IONS; IONS; PATHOLOGY; RADIOTHERAPY;

CARBON ION RADIATION THERAPIES; DOSE LIMITING TOXICITY; EVALUATION CRITERIA; GASTRIC ULCERS; LOCALLY ADVANCED PANCREATIC CANCERS; MAXIMUM TOLERATED DOSE; METHODS AND MATERIALS; OVERALL SURVIVAL RATES;

PATIENT TREATMENT;

FLUORODEOXYGLUCOSE F 18; GEMCITABINE; HEMOSTATIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; RADIOSENSITIZING AGENT;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; DISTANT METASTASIS; DRUG DOSE INCREASE; FEMALE; HUMAN; INFECTION; ION THERAPY; LEUKOPENIA; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PANCREAS CARCINOMA; PEPTIC ULCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RECOMMENDED DRUG DOSE; SALVAGE THERAPY; STOMACH HEMORRHAGE; STOMACH ULCER; SYSTEMIC THERAPY; THROMBOCYTOPENIA; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CARCINOMA, PANCREATIC DUCTAL; DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; RADIOTHERAPY DOSAGE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, PANCREATIC DUCTAL; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAVY ION RADIOTHERAPY; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 84957644663     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.12.362     Document Type: Article

References (19)

1. H.A. Burris 3rd, M.J. Moore, J. Andersen, and et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial J Clin Oncol 15 1997 2403 2413
2. H. Ishii, J. Furuse, N. Boku, and et al. Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506 Jpn J Clin Oncol 40 2010 573 579
3. R.A. Wolff, D.B. Evans, D.M. Gravel, and et al. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma Clin Cancer Res 7 2001 2246 2253
4. T. Kanai, M. Endo, S. Minohara, and et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy Int J Radiat Oncol Biol Phys 44 1999 201 210
5. T. Kanai, Y. Furusawa, K. Fukutsu, and et al. Irradiation of mixed beam and design of spread-out bragg peak for heavy-ion radiotherapy Radiat Res 147 1997 78 85
6. Society JP Classification of Pancreatic Carcinoma (English Edition) 3rd ed. 2011 Kanehara Tokyo
7. S. Mori, R. Hara, T. Yanagi, and et al. Four-dimensional measurement of intrafractional respiratory motion of pancreatic tumors using a 256 multi-slice CT scanner Radiother Oncol 92 2009 231 237
8. K. Terashima, Y. Demizu, N. Hashimoto, and et al. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis Radiother Oncol 103 2012 25 31
9. E. Ben-Josef, M. Schipper, I.R. Francis, and et al. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 84 2012 1166 1171
10. M. Ikeda, S. Okada, K. Tokuuye, and et al. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer Br J Cancer 86 2002 1551 1554
11. T. Okusaka, Y. Ito, H. Ueno, and et al. Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer Br J Cancer 91 2004 673 677
12. C.J. McGinn, M.M. Zalupski, I. Shureiqi, and et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 19 2001 4202 4208
13. H. Kawakami, T. Uno, K. Isobe, and et al. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas Int J Radiat Oncol Biol Phys 62 2005 1357 1362
14. J.D. Murphy, S. Adusumilli, K.A. Griffith, and et al. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801 808
15. J. Westerdahl, A. Andren-Sandberg, and I. Ihse Recurrence of exocrine pancreatic cancer-local or hepatic? Hepatogastroenterology 40 1993 384 387
16. S.S. Nitecki, M.G. Sarr, T.V. Colby, and et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221 1995 59 66
17. W. Sun, C.N. Leong, Z. Zhang, and et al. Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: A pooled analysis of clinical evidence Radiat Oncol 5 2010 28
18. J.M. Herman, D.T. Chang, K.A. Goodman, and et al. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma Cancer 121 2015 1128 1137
19. M.L. Rothenberg, J.L. Abbruzzese, M. Moore, and et al. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma Cancer 78 1996 627 632